If you’ve worked in healthcare long enough, you’ve seen the exact same dynamic play out year after year: A perioperative CVA committee sits down to review a product, a device, or a clinical pathway change, and half the room quietly looks at their shoes.
Why?
Because the people in the room, brilliant clinicians, no doubt, simply don’t feel comfortable voting on initiatives outside their own specialty. Surgeons don’t want to weigh in on something GI uses. GI doesn’t want to vote on ortho. Ortho stays out of neuro.
And even when the evidence is airtight – cost, outcomes, safety, peer-reviewed studies – siloed governance leads to stalled decisions, watered-down recommendations, and a whole lot of, “Let’s table it until next month.” Sound familiar?
This isn’t a people problem. It’s a structure problem. And it’s exactly why Clinical Value Analysis (CVA) must evolve.
The Structure We Inherited Is Not the Structure We Need
Most CVA models were built 15–20 years ago when supply chain’s primary role was product review and cost management, not clinical integration, not system-wide performance, not reimbursement strategy. Back then, a siloed committee structure made sense. Today, it is actively holding organizations back.
Health systems are navigating:
- Rising labor costs
- Increased clinical variation
- Site-level drift
- Quality penalties
- Reimbursement pressure
- Fragmented data
- Extended length of stay
- Standardization challenges
- The need for rapid technology adoption
Yet CVA, the very function responsible for aligning cost with quality and outcomes, still sits off to the side in many organizations, advising, recommending, and influencing…but not fully embedded where decisions actually get made and carried forward.
Enter: The Clinical Operational Service Line (COSL) Model.
Why COSL Is the Natural Home for CVA
A COSL governance structure exists for a simple reason: It aligns clinical, financial, operational, and strategic performance for every service line across the organization. It has the authority. It has the accountability. It is closer to the bedside and closer to the outcomes.
CVA belongs there for five big reasons:
1. Service lines own outcomes, and CVA is an outcomes engine.
Length of stay, readmissions, complications, resource utilization, case cost…these metrics sit inside the service line ecosystem. CVA should not be “advisory.” It should be a core function of operational leadership.
2. Decision making becomes credible, fast, and specialty-appropriate.
Neuro doesn’t need to vote on GI. Cardiology doesn’t need to weigh in on ortho. The subject matter experts are where they belong: in THEIR service line, deciding on THEIR outcomes. This eliminates the awkward cross-specialty voting culture that bogs down traditional CVA committees.
3. Evidence thrives when the right people own the decision.
Financial models, safety data, reimbursement impact, complication reductions – these hit differently when presented to the leaders and physicians who directly experience the problem.
4. CVA finally gets “stickiness” at the bedside.
One of the biggest failures in CVA today is the gap between decision and implementation. Service lines, with nursing, operations, physicians, and supply chain leaders sitting together, ensure decisions do not drift or die. You don’t need 10 reminder emails. You don’t need another subcommittee. You need alignment from day one. COSL gives you that.
5. Integration solves the silo problem, permanently.
Standardization, technology, contracting, preference cards, clinical pathways, and reimbursement alignment all live inside a COSL structure already. CVA simply plugs into the engine that owns them.
The Real Problem: CVA Has Been Operating Without Authority
Let’s be honest: Most CVA programs function like consultants inside their own health system.
They recommend.
They model.
They present.
They escalate.
They hope.
But they rarely have the authority to enforce or sustain.
That responsibility lives with operations, the service line. Integrating CVA into COSL solves the long-standing authority gap. It marries the analytics rigor of value analysis with the operational execution horsepower of service line leadership.
The result? A governance model where decisions are made by the people who feel the outcomes, not by a cross-specialty committee where half the room doesn’t feel qualified to vote.
What This Looks Like in Practice
Inside a COSL structure, CVA becomes a cross-functional team embedded into each service line.
The new structure includes:
- A service line chair/medical director
- Nursing leaders from inpatient and procedural areas
- Operational leaders
- Finance/business partners
- Supply chain (category manager, analyst, VA leader)
- Quality, safety, and infection prevention when needed
Together, they solve:
- Device and product introduction
- Standardization
- Clinical pathway alignment
- Reimbursement impact
- Technology requests
- Preference card optimization
- Variation reduction
- Performance analytics
- Vendor management
- TCO & ROI modeling
- Contract alignment with outcomes
Instead of sitting on the sidelines, CVA becomes the fuel that powers service line performance.
The Results Speak for Themselves
Organizations that move CVA under COSL experience:
- Faster implementation
- Higher physician engagement
- Stronger clinical alignment
- Reduced variation
- Better adoption of standardization
- Consistent contract compliance
- Improved supply utilization
- Higher reimbursement accuracy
- Measurable outcome improvement
- Better cost-to-quality balance
It’s not a theory. It’s a structural truth: Authority drives adoption. Integration drives results.
The Future of CVA Is Not a Committee – It’s a System.
The industry is shifting from product decisioning to clinical transformation, reimbursement alignment, and total performance improvement.
CVA can either:
- Stay in its traditional silo and keep fighting for influence, or
- Integrate into COSL and lead from within.
For health systems that want speed, accountability, and operational follow-through, the answer is clear. CVA isn’t a separate function anymore. It is a strategic engine inside the service line.
And when CVA, operations, nursing, physicians, finance, and supply chain share one governance structure with shared metrics and shared accountability…decisions finally stick, outcomes improve, and the system begins to work the way it was meant to.
Closing Thought
If you’ve ever sat in a CVA meeting and watched brilliant clinicians hesitate to vote because, “That’s not my specialty,” that moment tells you everything you need to know.
CVA has outgrown the room it was built in.
It’s time we place it where it truly belongs: inside the heart of clinical operations, inside the service line, driving outcomes with authority, speed, and purpose.
Article by:
Angelique Beslic, Sr. Director of Supply Chain, Legacy Health; Executive Consultant and Principal of Bridge Ventures, LLC
Angelique is the Executive Consultant and Principal of Bridge Ventures, LLC, a Supply Chain Leadership and Education Organization. Angelique is also the Sr. Director of Supply Chain for Legacy Health. In her leadership role, her duties include all levels of procurement, contracting, strategic sourcing, clinical value analysis, and decision support.
Articles you may like:
